120 related articles for article (PubMed ID: 11264043)
1. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
Krcmery V; Bilíková E; Svetlansky I; Kovacicová G
Clin Infect Dis; 2001 Apr; 32(7):1110-2. PubMed ID: 11264043
[No Abstract] [Full Text] [Related]
2. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
3. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
4. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
Hurley JC
Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
[No Abstract] [Full Text] [Related]
5. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant enterococcal bacteremia.
Boyce JM
Clin Infect Dis; 2002 Dec; 35(11):1445-6; discsussion 1446. PubMed ID: 12439814
[No Abstract] [Full Text] [Related]
7. [Vancomycin (VCM) resistant enterococci (VRE)].
Fujimoto S; Ike Y; Takahashi A; Yomoda S; Murakami M
Nihon Rinsho; 2003 Mar; 61 Suppl 3():182-9. PubMed ID: 12717969
[No Abstract] [Full Text] [Related]
8. Vancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapy.
Nannini EC
Clin Infect Dis; 2006 Apr; 42(8):1203-4; author reply 1204-5. PubMed ID: 16575743
[No Abstract] [Full Text] [Related]
9. First recurrent infection with vancomycin-resistant enterococcus from Turkey.
Citak EC; Oguz A; Karadeniz C; Okur V; Basustaoglu A; Arman D
J Infect; 2006 Sep; 53(3):e147-50. PubMed ID: 16413059
[TBL] [Abstract][Full Text] [Related]
10. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
11. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Matar MJ; Tarrand J; Raad I; Rolston KV
Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
[TBL] [Abstract][Full Text] [Related]
12. [Enterococcal infections. Clinical findings and treatment considering antibiotic resistance in Denmark].
Olesen HV; Møller JK
Ugeskr Laeger; 2002 Apr; 164(18):2386-90. PubMed ID: 12024841
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
Lodise TP; McKinnon PS; Tam VH; Rybak MJ
Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin resistance and mortality associated with enterococcal bacteremia.
Lautenbach E; Brennan PJ
Clin Infect Dis; 1997 Mar; 24(3):530-1. PubMed ID: 9114224
[No Abstract] [Full Text] [Related]
15. Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors, and strain relatedness.
Baran J; Riederer KM; Ramanathan J; Khatib R
Clin Infect Dis; 2001 May; 32(9):1381-3. PubMed ID: 11303278
[TBL] [Abstract][Full Text] [Related]
16. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
17. First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China.
Cao B; Liu Y; Song S; Li R; Wang H; Wang C
Int J Antimicrob Agents; 2008 Sep; 32(3):279-81. PubMed ID: 18614337
[No Abstract] [Full Text] [Related]
18. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
Jones RN
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S13-24. PubMed ID: 16323115
[TBL] [Abstract][Full Text] [Related]
19. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
